ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Incorporating MRI for Early Prostate Cancer Detection
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 203922" data-attributes="member: 13851"><p>[MEDIA=youtube]bgsS2rsKyh8[/MEDIA]</p><p></p><p></p><p><strong>Screening and Prevention of Prostate Cancer 2021 (Part 3): Incorporating MRI for Early Detection – Summary:</strong></p><p></p><p><em>In the final part of a 3-part series, Sigrid V. Carlsson, MD, Ph.D., MPH, Assistant Attending Epidemiologist at Memorial Sloan Kettering Cancer Center, considers the current role of MRI in the early detection of prostate cancer. She notes that while the various major prostate cancer guidelines recommend using multiparametric (mp)MRI before biopsy, they do not recommend using it as an initial screening tool. Also, while the EAU guidelines suggest that systematic biopsies can be omitted in patients with negative mpMRIs, the evidence for doing so is weak, and the NCCN guidelines take the more conservative approach of advocating for the inclusion of systematic biopsy with mpMRI. Dr. Carlsson continues by analyzing some of these limitations of mpMRI, explaining that its accuracy is highly dependent on the expertise of who is reading it. For this reason, it may be too early to omit biopsies in men with negative MRIs unless the MRI was performed at a specialized clinic. Furthermore, Dr. Carlsson notes, many of the studies showing the benefit of mpMRI were performed at centers of excellence, and may not reflect the limitations of most institutions. She opines that a chain is only as strong as its weakest link, and notes that pre-biopsy MRI requires access to high-quality mpMRI studies, optimal reading of scans, and access to high-quality mpMRI-targeted biopsy in order to truly be successful. Dr. Carlsson concludes by listing a variety of ongoing studies into imaging for prostate cancer screening and noting that evidence suggests unnecessary biopsies may be reduced in the future by combining mpMRI and different biomarker tests.</em></p><p></p><p></p><p>[ATTACH=full]15368[/ATTACH]</p><p>[ATTACH=full]15369[/ATTACH]</p></blockquote><p></p>
[QUOTE="madman, post: 203922, member: 13851"] [MEDIA=youtube]bgsS2rsKyh8[/MEDIA] [B]Screening and Prevention of Prostate Cancer 2021 (Part 3): Incorporating MRI for Early Detection – Summary:[/B] [I]In the final part of a 3-part series, Sigrid V. Carlsson, MD, Ph.D., MPH, Assistant Attending Epidemiologist at Memorial Sloan Kettering Cancer Center, considers the current role of MRI in the early detection of prostate cancer. She notes that while the various major prostate cancer guidelines recommend using multiparametric (mp)MRI before biopsy, they do not recommend using it as an initial screening tool. Also, while the EAU guidelines suggest that systematic biopsies can be omitted in patients with negative mpMRIs, the evidence for doing so is weak, and the NCCN guidelines take the more conservative approach of advocating for the inclusion of systematic biopsy with mpMRI. Dr. Carlsson continues by analyzing some of these limitations of mpMRI, explaining that its accuracy is highly dependent on the expertise of who is reading it. For this reason, it may be too early to omit biopsies in men with negative MRIs unless the MRI was performed at a specialized clinic. Furthermore, Dr. Carlsson notes, many of the studies showing the benefit of mpMRI were performed at centers of excellence, and may not reflect the limitations of most institutions. She opines that a chain is only as strong as its weakest link, and notes that pre-biopsy MRI requires access to high-quality mpMRI studies, optimal reading of scans, and access to high-quality mpMRI-targeted biopsy in order to truly be successful. Dr. Carlsson concludes by listing a variety of ongoing studies into imaging for prostate cancer screening and noting that evidence suggests unnecessary biopsies may be reduced in the future by combining mpMRI and different biomarker tests.[/I] [ATTACH type="full" alt="Screenshot (5829).png"]15368[/ATTACH] [ATTACH type="full" alt="Screenshot (5830).png"]15369[/ATTACH] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Incorporating MRI for Early Prostate Cancer Detection
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top